Comparison of TP53 mutation analysis findings for tar pitch dermatopathy and ionizing radiation-related skin cancer

被引:0
|
作者
Ishino, Keiko [1 ]
Yamada, Hidetaka [1 ]
Kahyo, Tomoaki [1 ]
Hino, Ryosuke [2 ]
Nakamura, Motonobu [2 ]
Shimajiri, Shohei [3 ]
Hisaoka, Masanori [4 ]
Kasami, Masako [5 ]
Tokura, Yoshiki [6 ]
Sugimura, Haruhiko [1 ]
机构
[1] Hamamatsu Univ, Sch Med, Dept Tumor Pathol, 1-20-1 Handayama,Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[2] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka, Japan
[3] Univ Occupat & Environm Hlth, Dept Surg Pathol, Kitakyushu, Fukuoka, Japan
[4] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Oncol, Kitakyushu, Fukuoka, Japan
[5] Iwata City Hosp, Div Diagnost Pathol, Iwata, Shizuoka, Japan
[6] Chutoen Gen Med Ctr, Allerg Dis Res Ctr, Kakegawa, Shizuoka, Japan
关键词
TP53; mutation spectrum; Tar-pitch dermatopathy; skin cancer; radiation; environmental carcinogenesis; P53; MUTATION;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Tar has been well known as a carcinogen ever since Yamagiwa artificially induced carcinogenesis for the first time by painting a rabbit ear with tar 100 years ago. While humans can be exposed to tar under numerous circumstances, few molecular pathological analyses of skin lesions caused by "tar pitch dermatopathy" have been performed because tar pitch dermatopathy itself is currently rare. Methods: A mutation analysis of TP53 was conducted using long-term stored formalin-fixed, paraffin-embedded tissue specimens of tar pitch dermatopathy in 4 subjects; a similar analysis of radiation-induced skin cancer in 2 subjects was also performed for comparison. Multiple sites were analyzed. Results: Among the specimens from the 4 subjects with tar pitch dermatopathy, the mutations c.625A>T and c.715A>G were each found in 1 of the lesion specimens, whereas the wild type for TP53 was seen in all the non-tumorous skin samples from these cases. The additional mutation c.503A>C was also detected in a different portion of the specimen from the case in which c.715A>G had been detected. In contrast, in 1of the 2 cases with radiation-induced skin cancer (3 squamous cell carcinoma lesions), the novel mutations c.224delC and c.470delT were found at dipyrimidine sites of TP53 . Thus, the mutation spectrum found in tar pitch dermatopathy did not include G>T transversions arising from benzo(a)pyrene, as expected, but instead included the mutation c.625A>T, which is prevalent among tobacco-related cancers according to the IARC database. Conclusions: Skin malignancy developing under peculiar conditions provides an opportunity to investigate the human reality of environmental carcinogenesis. Although a small piece of data this information will be helpful for understanding human skin carcinogenesis in terms of occupational exposure to environmental substances and informative in precision medicine especially in precision prevention.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Prognostic significance of TP53 accumulation in human primary breast cancer: Comparison between a rapid quantitative immunoassay and SSCP analysis
    deWitte, HH
    Foekens, JA
    Lennerstrand, J
    Smid, M
    Look, MP
    Klijn, JGM
    Benraad, TJ
    Berns, EMJJ
    INTERNATIONAL JOURNAL OF CANCER, 1996, 69 (02) : 125 - 130
  • [42] Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi-omics analysis
    Toyoda, Tomoaki
    Miura, Nami
    Kato, Shingo
    Masuda, Takeshi
    Ohashi, Ryuji
    Matsushita, Akira
    Matsuda, Fumio
    Ohtsuki, Sumio
    Katakura, Akira
    Honda, Kazufumi
    CANCER SCIENCE, 2024, 115 (11) : 3622 - 3635
  • [43] TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysis
    Gu, Jincui
    Zhou, Yanbin
    Huang, Lixia
    Ou, Weijun
    Wu, Jian
    Li, Shaoli
    Xu, Junwen
    Feng, Jinlun
    Liu, Baomo
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (06) : 705 - 713
  • [44] Higher TP53 somatic mutation prevalence from liquid biopsy analysis in smoker non-small-cell lung cancer patients
    Erdem, H.
    Bahsi, T.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 558 - 558
  • [45] TP53 mutation as predictive factor of platinum response in BRCA-mutated ovarian cancer: A prospective case-series analysis.
    Lai, Eleonora
    Neri, Manuela
    Sanna, Elisabetta
    Nemolato, Sonia
    Bardanzellu, Fabio
    Scartozzi, Mario
    Giglio, Sabrina
    Maccio, Antonio
    Madeddu, Clelia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 128 - 128
  • [46] Analysis of therapy-related MDS/AML identifies somatic mutations in nearly all samples and shorter survival associated with TP53 loss or mutation
    Shih, A.
    Chung, S. S.
    Abdel-Wahab, O.
    Dolezal, E. K.
    Park, C. Y.
    Nimer, S. D.
    Levine, R. L.
    Klimek, V. K.
    LEUKEMIA RESEARCH, 2013, 37 : S148 - S149
  • [47] Analysis of TP53 Codon72, and p21 Codon31 Polymorphisms in CLL Patients Exposed to Ionizing Radiation Due to the Chernobyl NPP Accident
    Bilous, Nadiia
    Abramenko, Iryna
    Chumak, Anatoliy
    Martina, Zoya
    Kryachok, Iryna
    Filonenko, Iryna
    BLOOD, 2012, 120 (21)
  • [48] Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients
    Erdem, Haktan Bagis
    Alay, Mustafa Tarik
    Ozdemir, Zeynep
    Cevik, Ezgi
    Ates, Ozturk
    Karacin, Cengiz
    Sahin, Ibrahim
    Dogan, Mutlu
    Bahsi, Taha
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2024, 828
  • [49] TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with anti-angiogenic or standard chemotherapy regimens.
    Fischer, Nicholas William
    Graziano, Francesco
    Bagaloni, Irene
    Di Bartolomeo, Maria
    Lonardi, Sara
    Vincenzi, Bruno
    Fornaro, Lorenzo
    Ongaro, Elena
    Aprile, Giuseppe
    Bisonni, Renato
    Prisciandaro, Michele
    Gariepy, Jean
    Loupakis, Fotios
    Sarti, Donatella
    Del Prete, Michela
    Catalano, Vincenzo
    Magnani, Mauro
    Ruzzo, Annamaria
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Ionizing radiation enhances the expression of the nonsteroidal anti-inflammatory drug-activated gene (NAG1) by increasing the expression of TP53 in human colon cancer cells
    Okazaki, R
    Moon, Y
    Norimura, T
    Eling, T
    RADIATION RESEARCH, 2006, 165 (02) : 125 - 130